Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster

Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa Leishmania infantum for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of L. infantum. Despit...

Full description

Bibliographic Details

Main Authors:	Maia Gonçalves, Ana Alice, Ottino, Jennifer, Costa Leite, Jaqueline, Aparecida Resende, Lucilene, Melo Júnior, Otoni Alves, Silveira, Patrícia, Santos Cardoso, Mariana, Toshio Fujiwara, Ricardo, Lacerda Bueno, Lilian, Lima Santos, Renato, Furtado de Carvalho, Tatiane, Martins Garcia, Giani, de Oliveira Paes, Paulo Ricardo, Sobreira Galdino, Alexsandro, Chávez Fumagalli, Miguel Angel, Martins Melo, Marília, Silveira Lemos, Denise, Martins Filho, Olindo Assis, Ornelas Dutra, Walderez, Furtado Mosqueira, Vanessa Carla, Cordeiro Giunchetti, Rodolfo
Format:	Artículo
Language:	Inglés
Published:	MDPI 2023
Subjects:	Visceral leishmaniasis Nanotechnology Vaccine https://purl.org/pe-repo/ocde/ford#4.03.01 Leishmaniasis Vaccines Leishmania
Online Access:	https://hdl.handle.net/20.500.12955/2090 https://doi.org/10.3390/vaccines11010111